Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2963651000168115 | Magnesium Sulfate Heptahydrate (Phebra) (magnesium sulfate heptahydrate 2.5 g / 5 mL) injection, 10 x 5 mL vials (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2965151000168112 | Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 10 x 5 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 10 x 5 mL vials | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 10 x 5 mL vials | Is a | Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 10 x 5 mL vials | true | Inferred relationship | Some | ||
| Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 10 x 5 mL vials | has container type | vial | true | Inferred relationship | Some | ||
| Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 10 x 5 mL vials | has TP | Magnesium Sulfate Heptahydrate (Phebra) | true | Inferred relationship | Some | ||
| Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 10 x 5 mL vials | has TPUU | Magnesium Sulfate Heptahydrate (Phebra) 2.5 g/5 mL injection, 5 mL vial | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR